chr13-48233441-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_021999.5(ITM2B):c.81C>T(p.Leu27Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,540,578 control chromosomes in the GnomAD database, including 825 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 250 hom., cov: 31)
Exomes 𝑓: 0.011 ( 575 hom. )
Consequence
ITM2B
NM_021999.5 synonymous
NM_021999.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.638
Genes affected
ITM2B (HGNC:6174): (integral membrane protein 2B) Amyloid precursor proteins are processed by beta-secretase and gamma-secretase to produce beta-amyloid peptides which form the characteristic plaques of Alzheimer disease. This gene encodes a transmembrane protein which is processed at the C-terminus by furin or furin-like proteases to produce a small secreted peptide which inhibits the deposition of beta-amyloid. Mutations which result in extension of the C-terminal end of the encoded protein, thereby increasing the size of the secreted peptide, are associated with two neurogenerative diseases, familial British dementia and familial Danish dementia. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 13-48233441-C-T is Benign according to our data. Variant chr13-48233441-C-T is described in ClinVar as [Benign]. Clinvar id is 1210019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-48233441-C-T is described in Lovd as [Likely_benign]. Variant chr13-48233441-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.638 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0967 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITM2B | NM_021999.5 | c.81C>T | p.Leu27Leu | synonymous_variant | 1/6 | ENST00000647800.2 | NP_068839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITM2B | ENST00000647800.2 | c.81C>T | p.Leu27Leu | synonymous_variant | 1/6 | NM_021999.5 | ENSP00000497221.1 |
Frequencies
GnomAD3 genomes AF: 0.0342 AC: 5205AN: 151992Hom.: 246 Cov.: 31
GnomAD3 genomes
AF:
AC:
5205
AN:
151992
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0203 AC: 2959AN: 145564Hom.: 131 AF XY: 0.0221 AC XY: 1758AN XY: 79602
GnomAD3 exomes
AF:
AC:
2959
AN:
145564
Hom.:
AF XY:
AC XY:
1758
AN XY:
79602
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0107 AC: 14904AN: 1388478Hom.: 575 Cov.: 30 AF XY: 0.0122 AC XY: 8358AN XY: 686650
GnomAD4 exome
AF:
AC:
14904
AN:
1388478
Hom.:
Cov.:
30
AF XY:
AC XY:
8358
AN XY:
686650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0344 AC: 5232AN: 152100Hom.: 250 Cov.: 31 AF XY: 0.0343 AC XY: 2553AN XY: 74374
GnomAD4 genome
AF:
AC:
5232
AN:
152100
Hom.:
Cov.:
31
AF XY:
AC XY:
2553
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
420
AN:
3468
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at